Certainly the titles are different, however the purpose of the two organizations is extremely similar, with goals of epidemiology and public health, so as a general terminology I feel the comparison can be used for some convenience. But fair nonetheless. Obviously many variants of the disease have been around for some time, but as we increasingly see people get resistant we can anticipate more and more of these strains that can slip away from immunity being developed, which is concerning. and as they chip away at what immunity was provided by B cells and via the vaccine(few percentage points here and there) it definitely seems possible as Jesse Bloom mentions in a linked thread that we could run out of this current vaccines efficacy before long. necessitating another intense round of vaccine development that as we've seen in the USA, despite stunning initial results, are being rolled out like a train wreck. And T cell immunity will be important but absent cleaner data about vaccine persistence and without seeing what new strains are cooking up in the dakota's im just concerned.

get the vaccine, but damn covid is slippery.